Reporting owner · Q3 2026 · CIK 2110603

Cain Wettan Keeley M: insider trades.

Cain Wettan Keeley M reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.

Transactions
4
Purchases (P)
0
Sales (S)
0
Companies
1
Name as filed
Cain Wettan Keeley M

Companies

CompanyRelationshipTransactions
Gilead Sciences, Inc. (GILD)Officer · EVP Gen Counsel, Legal & Comp4

Transactions

4 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-10Gilead Sciences, Inc.M590—9,044Form 4
2026-09-10Gilead Sciences, Inc.F285$144.818,759Form 4
2026-08-10Gilead Sciences, Inc.F2,908$133.068,454Form 4
2026-08-10Gilead Sciences, Inc.M6,002—11,362Form 4

Questions

What stock did Cain Wettan Keeley M buy or sell?

Cain Wettan Keeley M reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.

Is Cain Wettan Keeley M the same person as other filers with this name?

This page covers SEC CIK 2110603 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/cain-wettan-keeley-m-2110603.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.